Hyperkalemia in Heart and Kidney Care

Executive summary

A high potassium result creates two linked risks: delayed urgent care and an unexamined long-term interruption of indicated treatment. In an observational CKD cohort after new hyperkalemia, 13.5% discontinued RAAS-inhibitor therapy within three months. The association with later adverse outcomes is not proof of causality; it supports teaching a deliberate assessment and reassessment process.

HEART RESERVE proposes one 60-minute enduring activity for primary care and cardiorenal teams. Evelyn’s changing symptoms, Sofia’s reversible contributors and Margaret’s evidence and medication-schedule decisions connect triage, prevention and follow-through. Original cases, feedback, a complete audio alternative and a worked result-review loop make clinical reasoning visible. The curriculum compares appropriate options and evidence limitations without a product-uptake objective. Independent clinical faculty and the accredited provider govern review and release.

The $60,850 prospective request includes $6,000 of defined educator work. Matched first responses measure learning; proposed transfer vignettes and a 60-day follow-up distinguish case application from reported practice. The public AstraZeneca hyperkalemia listing supplies a current topic-fit signal, not an award commitment. A complete application, activity-specific quote and accepted faculty roles are required. Planning allows a December 1 submission, no funded start before February 1 and a tentative April 1, 2027 learner release.

Why HEART RESERVE

HEART RESERVE connects a woman’s history with current evidence, the next clinical action and the person responsible for follow-through. Its contributed original curriculum, consistent case structure and equivalent text/audio options provide a concrete starting point for faculty review. Lisa Zahakos, RPA-C supplies the clinical educator perspective; independent specialty faculty, the accredited provider and a contracted delivery organization supply distinct review and delivery functions. No unverified organizational reach, accreditation or prior grant outcomes are claimed.

Funding fit

AstraZeneca’s public educational-interest table lists hyperkalemia. The activity connects urgent triage, reversible contributors and product-specific maintenance/monitoring decisions. Confirm the funding indicator and all current eligibility, attachments and dates within the application process; the topic listing is not an award commitment.

Educational design

Three original cases use an initial decision, a changed circumstance, evidence-based feedback and an accountable follow-up plan. A separate review exhibit supplies three proposed transfer vignettes mapped to existing baseline concepts. The accredited provider validates case content, timing, assessment and media equivalence before release.

Outcomes and limits

The current baseline and first posttest share three items. Report paired n, absolute percentage-point change, item-level results and uncertainty, with retries separate. The 15-percentage-point gain is a planning target; high baseline scores may create a ceiling. Repeated items measure immediate learning with recall limitations. The proposed transfer form changes the clinical surface while preserving the mapped concept. Before using it for a Moore level 4 claim, independent clinical and assessment reviewers must approve the key, equivalence, difficulty and analysis, then pilot it with representative learners. Use it to replace matched posttest slots only after approval, preserving six final questions and the time target. It is not an additional required test in the present activity. Report unpaired data and nonresponse; do not infer causality, observed clinical performance or patient benefit.

Budget and value

The prospective request is $60,850, including $6,000 in proposed educator work (9.86%). Completed development and application preparation are contributed. Final contracts must aggregate every payment to Lisa and keep it below 20% of the final funded total. Independent review, hosting and outcomes have separate payees. Reconcile shared content, included host services and audience overlap once.

Delivery and partner roles

All costs are unquoted; the $20,000 host allowance is not the pregnancy activity’s quote. The accredited provider controls credit, disclosures, educational independence and commercial-support arrangements. ReachMD is an alternative delivery discussion requiring its own agreed formats and quote; it is not an additional confirmed partner or a service included in myCME’s offer.

Evidence still required

Legal applicant, topic-specific provider/host quotes, clinical appointments, final dates and complete portal attachments.

Decision-to-outcome plan

Evelyn: changed symptoms change the destination: Make the urgent disposition decision before discussing longer-term prevention; an ECG cannot justify a delay in this scenario. The current baseline concept is K1; proposed transfer item TR1 remains a separate review exhibit until clinical/assessment approval and pilot.

Sofia: review contributors before a permanent stop: Assess safety, correct reversible contributors and schedule reassessment while explicitly reconsidering the ongoing organ-protection indication. The current baseline concept is K3; proposed transfer item TR2 remains a separate review exhibit until clinical/assessment approval and pilot.

Margaret: the best biochemical plan must work at home: Compare product-specific cautions, spacing, access and monitoring; do not rank therapies by unrelated trial results or promise emergency rescue. The current baseline concept is K5; proposed transfer item TR3 remains a separate review exhibit until clinical/assessment approval and pilot.

The active activity contains three baseline items, six formative decisions and six final items. The three repeated baseline/post items measure immediate learning with recall limitations. Link each result to its objective, retain first attempts and report retries separately. Proposed transfer cases must replace mapped final slots only after approval; they are not additional current completion requirements. Report later self-reported actions and access barriers separately from case scores.

Independence and acceptance

Independent clinical faculty and the accredited provider determine content, evidence balance, assessment keys and release. Commercial supporters do not select recommendations or products. Each funded line requires an eligible future deliverable, documented hours/rate or units, and accepted work. Existing development and grant preparation are contributed. Andrea’s October 9 guidance concerns management fees above 20%; the separate user-directed ceiling aggregates all compensation to Lisa below 20% of the final funded amount. Mike’s written quote applies only to Pregnancy Is Heart History. Other courses require their own agreed scopes and quotes.

Needs evidence

An et al., 2023; observational RAAS-inhibitor discontinuation

Apply the population, setting and study limitations stated in the needs assessment; this source does not establish the same gap in every proposed learner.